Investigating cognitive placebo effects in reinforcement learning:A computational modelling approach
研究强化学习中的认知安慰剂效应:一种计算建模方法
基本信息
- 批准号:392135994
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Fellowships
- 财政年份:2017
- 资助国家:德国
- 起止时间:2016-12-31 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Placebos and nocebos are physiologically inert substances (e.g. pharmaceuticals) or simulated interventions (e.g. medical devices), which produce complex psychobiological responses in the participants despite the fact that they do not have any direct therapeutic effects. Whereas the term "placebo" describes positive effects (i.e., improvement in symptoms), "nocebo" relates to any negative effects (i.e., worsening of symptoms) of a simulated treatment. So far, the fundamental paradigms of placebo/nocebo effects have been primarily confined to the pain or motor domains and our knowledge about cognitive placebo effects remains poorly understood. In this research fellowship, we will ask the questions (1) whether verbal suggestions in conjunction with active sham protocols of transcranial direct current stimulation (tDCS) can induce cognitive placebo effects in different forms of reward learning and (2) characterize the role of uncertainty-based verbal suggestions in inducing cognitive placebo effects. To address these questions, we will focus on reward learning by using a computational modeling approach called reinforcement learning. We will concentrate on two forms of control systems of reinforcement learning that are called model-free (MF) and model-based (MB) systems. In order to dissociate between the MF and MB control systems, we will employ a well-characterized sequential two-choice Markov decision task. To induce cognitive placebo effects, we will use active sham protocols of tDCS in conjunctions with the systematic manipulation of uncertainty about treatment efficacy by employing verbal suggestions. To better understand the relationship between uncertainty about treatment efficacy and placebo response, participant will be randomly allocated into one control and three placebo manipulation groups, namely low-, mid- and high-uncertainty groups. The present research fellowship will contribute to the understanding how cognitive placebo effects are generated and maintained, which is a fundamental question in basic neuroscience research and it has important implications in clinical practice. Furthermore, this research fellowship will greatly extend my expertise in Bayesian statistical analysis and in computational modeling of reinforcement learning.
安慰剂和反安慰剂是生理惰性物质(如药物)或模拟干预措施(如医疗设备),尽管它们没有任何直接的治疗效果,但它们会在参与者中产生复杂的心理生物学反应。术语“安慰剂”描述的是积极效果(即症状的改善),而“反安慰剂”涉及模拟治疗的任何负面效果(即症状的恶化)。到目前为止,安慰剂/反安慰剂效应的基本范式主要局限于疼痛或运动领域,我们对认知安慰剂效应的了解仍然很少。在本研究中,我们将提出以下问题:(1)言语暗示结合经颅直流电刺激(tDCS)的主动假方案是否能在不同形式的奖励学习中诱导认知安慰剂效应;(2)表征基于不确定性的言语暗示在诱导认知安慰剂效应中的作用。为了解决这些问题,我们将通过使用一种称为强化学习的计算建模方法来关注奖励学习。我们将集中讨论两种形式的强化学习控制系统,即无模型(MF)和基于模型(MB)的系统。为了分离MF和MB控制系统,我们将采用一个特征良好的顺序二选择马尔可夫决策任务。为了诱导认知安慰剂效应,我们将使用主动的假性tDCS方案,并通过使用口头建议来系统地操纵治疗效果的不确定性。为了更好地了解治疗疗效的不确定性与安慰剂反应之间的关系,参与者将被随机分为一个对照组和三个安慰剂操纵组,即低、中、高不确定性组。本研究将有助于理解认知安慰剂效应是如何产生和维持的,这是基础神经科学研究的一个基本问题,在临床实践中具有重要意义。此外,这个研究奖学金将极大地扩展我在贝叶斯统计分析和强化学习的计算建模方面的专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dr. Zsolt Turi, Ph.D.其他文献
Dr. Zsolt Turi, Ph.D.的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
外周犬尿氨酸通过脑膜免疫致海马BDNF水平降低介导术后认知功能障碍
- 批准号:82371193
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
- 批准号:82371192
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
- 批准号:82371213
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
年龄和手术应激强度在术后远期认知功能障碍发生中的作用与机制研究
- 批准号:81141066
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
面向认知网络的自律计算模型及评价方法研究
- 批准号:60973027
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh
硝唑尼特治疗孟加拉国营养不良儿童隐孢子虫感染的随机对照试验
- 批准号:
10551559 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cognitively engaging walking exercise and neuromodulation to enhance brain function in older adults
认知性步行锻炼和神经调节可增强老年人的大脑功能
- 批准号:
10635832 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Improving Sleep and AD Biomarkers: A Pilot RCT of Citicoline
改善睡眠和 AD 生物标志物:胞二磷胆碱的试点随机对照试验
- 批准号:
10585583 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Methylphenidate for the treatment of epilepsy-related cognitive deficits: a randomized, double-blind, placebo-controlled trial
哌醋甲酯治疗癫痫相关认知缺陷:一项随机、双盲、安慰剂对照试验
- 批准号:
10589709 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Intermittent Hypoxia Initiated Motor Plasticity in Individuals with Multiple Sclerosis
间歇性缺氧引发多发性硬化症患者的运动可塑性
- 批准号:
10593412 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
大麻二酚对有阿尔茨海默病风险的个体来说:一项随机安慰剂对照试验
- 批准号:
10677333 - 财政年份:2023
- 资助金额:
-- - 项目类别:
TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty
起飞:用酮酯对抗老年人的衰老,改善虚弱功能
- 批准号:
10640024 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Using Ketamine to enhance memory reconsolidation and extinction of overgeneralized fear in individuals diagnosed with PTSD
使用氯胺酮增强被诊断患有创伤后应激障碍 (PTSD) 的患者的记忆重新巩固和过度恐惧的消除
- 批准号:
10574049 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




